The HMB-FA randomized trial: Not Sure If….
Wow. It finally happened.
On first glance, I haven’t seen data this promising about a supplement since…ever. HMB (beta-hydroxy-beta-metahybutyrate) has been so _unpromising_ since its emergence back in the late 1990’s/early 2000’s, that I had basically stopped reading about it. And then Andrew Vigotsky mentioned me on Twitter and…well, consider me initially genuinely excited. Which is rare. Like, the next thing that might happen is a rain of frogs. But then I dug a little bit. Read More...